Ausgabe 3/2015
Inhalt (24 Artikel)
Intraarterial drug delivery for glioblastoma mutiforme
Shailendra Joshi, Jason A. Ellis, Eugene Ornstein, Jeffrey N. Bruce
Randomized controlled trials and neuro-oncology: should alternative designs be considered?
Alireza Mansouri, Samuel Shin, Benjamin Cooper, Archita Srivastava, Mohit Bhandari, Douglas Kondziolka
Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27Kip1
Hengliang Shi, Hui Gong, Kuan Cao, Shenshan Zou, Bingxin Zhu, Hanmo Bao, Yuxuan Wu, Yong Gao, Yuan Tang, Rutong Yu
VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme
Aleksandra Gruslova, David A. Cavazos, Jessica R. Miller, Eyal Breitbart, Yael C. Cohen, Livnat Bangio, Niva Yakov, Anu Soundararajan, John R. Floyd, Andrew J. Brenner
Involvement of CD9 and PDGFR in migration is evolutionarily conserved from Drosophila glia to human glioma
Astrid Jeibmann, Kathrin Halama, Hanna Theresa Witte, Su Na Kim, Kristin Eikmeier, Björn Koos, Christian Klämbt, Werner Paulus
Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression
Agustí Alentorn, Alberto Durán-Peña, Andigoni Malousi, Yannick Marie, Karima Mokhtari, Marc Sanson, Khê Hoang-Xuan, Jean-Yves Delattre, Ahmed Idbaih, Charles Vecht
A multi-resolution textural approach to diagnostic neuropathology reporting
Mohammad Faizal Ahmad Fauzi, Hamza Numan Gokozan, Brad Elder, Vinay K. Puduvalli, Christopher R. Pierson, José Javier Otero, Metin N. Gurcan
Colchicine derivative as a potential anti-glioma compound
Kuan-Min Fang, Jun-Jen Liu, Chun-Chun Li, Chih-Chi Cheng, Yun-Ti Hsieh, Kit Man Chai, Yu-An Lien, Shun-Fen Tzeng
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131
Michael A. Vogelbaum, Chen Hu, David M. Peereboom, David R. Macdonald, Caterina Giannini, John H. Suh, Robert B. Jenkins, Nadia N. Laack, David G. Brachman, Dennis C. Shrieve, Luis Souhami, Minesh P. Mehta
Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer
Daniel M. Trifiletti, Kara D. Romano, Zhiyuan Xu, Kelli A. Reardon, Jason Sheehan
Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1–4 brain metastases
Yufei Liu, Brian M. Alexander, Yu-Hui Chen, Margaret C. Horvath, Ayal A. Aizer, Elizabeth B. Claus, Ian F. Dunn, Alexandra J. Golby, Mark D. Johnson, Scott Friesen, Edward G. Mannarino, Matthew Wagar, Fred L. Hacker, Nils D. Arvold
Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries
Daniel M. Trifiletti, Nirav Patel, Cheng-Chia Lee, Andrew M. Romano, Jason P. Sheehan
Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design
Jordan A. Holmes, Anna K. Paulsson, Brandi R. Page, Lance D. Miller, Wennuan Liu, Jianfeng Xu, William H. Hinson, Glenn J. Lesser, Adrian W. Laxton, Stephen B. Tatter, Waldemar Debinski, Michael D. Chan
Clinical presentation and long-term outcome of primary spinal peripheral primitive neuroectodermal tumors
Xianzeng Tong, Xiaofeng Deng, Tao Yang, Chenlong Yang, Liang Wu, Jun Wu, Yuqiang Yao, Zhuang Fu, Shuo Wang, Yulun Xu
Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I–II trial of radiotherapy/tipifarnib combination
Soléakhéna Ken, Alexandra Deviers, Thomas Filleron, Isabelle Catalaa, Jean-Albert Lotterie, Jonathan Khalifa, Vincent Lubrano, Isabelle Berry, Patrice Péran, Pierre Celsis, Elizabeth Cohen-Jonathan Moyal, Anne Laprie
RETRACTED ARTICLE: Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients
Jian-tong Jiao, Jun Sun, Jian-fen Ma, Min-chao Dai, Jin Huang, Chen Jiang, Cheng Wang, Chao Cheng, Jun-fei Shao
Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases
Manmeet S. Ahluwalia, Samuel T. Chao, Michael W. Parsons, John H. Suh, Ding Wang, Tom Mikkelsen, Cathy J. Brewer, Kathy N. Smolenski, Cathy Schilero, Matthew Rump, Paul Elson, Lilyana Angelov, Gene H. Barnett, Michael A. Vogelbaum, Robert J. Weil, David M. Peereboom
IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy
Yasuo Iwadate, Tomoo Matsutani, Seiichiro Hirono, Shiro Ikegami, Natsuki Shinozaki, Naokatsu Saeki
Wound healing complications in brain tumor patients on Bevacizumab
Harshad Ladha, Tushar Pawar, Mark R. Gilbert, Jacob Mandel, Barbara O-Brien, Charles Conrad, Margaret Fields, Teresa Hanna, Carolyn Loch, Terri S. Armstrong
Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery
Andrew Yaeh, Tavish Nanda, Ashish Jani, Tzlil Rozenblat, Yasir Qureshi, Shumaila Saad, Jeraldine Lesser, Andrew B. Lassman, Steven R. Isaacson, Michael B. Sisti, Jeffrey N. Bruce, Guy M. McKhann II, Tony J. C. Wang
Brachytherapy in the treatment of recurrent aggressive falcine meningiomas
Hussam Abou Al-Shaar, Kaith K. Almefty, Mohammad Abolfotoh, Nils D. Arvold, Phillip M. Devlin, David A. Reardon, Jay S. Loeffler, Ossama Al-Mefty
Management of late extraneural recurrence of medulloblastoma without high-dose chemotherapy
Richard E. Phillips, Kevin J. Curran, Yasmin Khakoo
Genetic imprinting suggested by maternal DNA methylation in CNS hemangioblastoma with clinical phenotypes of VHL disease
Dexuan Ma, Ying Wang, Liangfu Zhou
Whither thiotepa (for patients in the USA)?
Christopher Dardis, Kelly Milton, Lynn Ashby